| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 317-324 |
| Number of pages | 8 |
| Journal | Drug Safety |
| Issue number | 17 |
| Publication status | Published - 1997 |
Research programs
- EMC 02-01-38-01-01
A Risk-Benefit Assessment of Octreotide in the Treatment of Acromegaly
- AJ (Aart-Jan) van der Lely
- , W.W. de Herder
- , S.W.J. Lamberts
Research output: Contribution to journal › Article › Academic › peer-review
11
Citations
(Scopus)